I. H. Acar Et Al. , "Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023
Acar, I. H. Et Al. 2023. Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA .
Acar, I. H., Atalay, F., Demirsoy, E. T., Can, F., GÜVEN, Z. T., Cetiner, M., ... TOMBAK, A.(2023). Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study. CLINICAL LYMPHOMA MYELOMA & LEUKEMIA .
Acar, Ibrahim Et Al. "Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study," CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023
Acar, Ibrahim H. Et Al. "Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA , 2023
Acar, I. H. Et Al. (2023) . "Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study." CLINICAL LYMPHOMA MYELOMA & LEUKEMIA .
@article{article, author={Ibrahim Halil Acar Et Al. }, title={Characteristics and Outcomes of Myelodysplastic Syndrome Patients Treated With Darbepoetin Alfa for Anemia in Turkey: A Multicenter Retrospective Study}, journal={CLINICAL LYMPHOMA MYELOMA & LEUKEMIA}, year=2023}